Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.3B |
| 2 |
Microsoft
MSFT
|
+$1.3B |
| 3 |
Advanced Micro Devices
AMD
|
+$925M |
| 4 |
S&P Global
SPGI
|
+$894M |
| 5 |
Tesla
TSLA
|
+$716M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$1.08B |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$972M |
| 3 |
Merck
MRK
|
+$295M |
| 4 |
Exelon
EXC
|
+$259M |
| 5 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$205M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.39% |
| 2 | Financials | 13.32% |
| 3 | Healthcare | 13.3% |
| 4 | Consumer Discretionary | 11.44% |
| 5 | Communication Services | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
Red River Bancshares
RRBI
$665M
| $4.18M | ﹤0.01% |
78,973
+4,084
| +5% | +$212K |
|
2902
Amplitude
AMPL
$1.33B
| $4.18M | ﹤0.01% |
226,657
-6,983
| -3% | -$212K |
|
2903
GeneDx Holdings
WGS
$2.08B
| $4.17M | ﹤0.01% |
41,162
+1,421
| +4% | +$158K |
|
2904
UBS Group
UBS
$176B
| $4.17M | ﹤0.01% |
213,276
-3,555
| -2% | -$67.2K |
|
|
XOMA
2905
DELISTED
Xoma
XOMA
| $4.16M | ﹤0.01% |
148,691
+1,983
| +1% | +$45.2K |
|
2906
RLX Technology
RLX
$2.37B
| $4.16M | ﹤0.01% |
2,339,998
-135,495
| -5% | -$403K |
|
2907
Vertex
VERX
$1.91B
| $4.16M | ﹤0.01% |
271,004
+3,620
| +1% | +$50.6K |
|
2908
Angi Inc
ANGI
$194M
| $4.14M | ﹤0.01% |
73,096
+331
| +0.5% | +$24.1K |
|
|
HLGN
2909
DELISTED
Heliogen, Inc.
HLGN
| $4.14M | ﹤0.01% |
+22,479
| New | +$4.1M |
|
2910
HF Foods Group
HFFG
$78.1M
| $4.13M | ﹤0.01% |
620,412
+31,710
| +5% | +$219K |
|
|
KNTE
2911
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $4.11M | ﹤0.01% |
365,103
+1,471
| +0.4% | +$16.2K |
|
2912
El Pollo Loco
LOCO
$503M
| $4.11M | ﹤0.01% |
353,668
+14,039
| +4% | +$181K |
|
2913
Matrix Service
MTRX
$325M
| $4.11M | ﹤0.01% |
499,564
+56,423
| +13% | +$426K |
|
2914
Spero Therapeutics
SPRO
$73M
| $4.1M | ﹤0.01% |
471,189
+14,005
| +3% | +$143K |
|
|
CBAY
2915
DELISTED
Cymabay Therapeutics
CBAY
| $4.09M | ﹤0.01% |
1,316,948
+165,743
| +14% | +$522K |
|
2916
Immunic
IMUX
$191M
| $4.08M | ﹤0.01% |
36,096
+4,096
| +13% | +$474K |
|
2917
Vroom Inc
VRM
$49.9M
| $4.07M | ﹤0.01% |
19,139
-1,560
| -8% | -$740K |
|
2918
Citius Pharmaceuticals
CTXR
$21.4M
| $4.07M | ﹤0.01% |
90,886
+8,917
| +11% | +$352K |
|
2919
Aldeyra Therapeutics
ALDX
$96.5M
| $4.06M | ﹤0.01% |
912,868
+60,108
| +7% | +$239K |
|
|
DZSI
2920
DELISTED
DZS Inc. Common Stock
DZSI
| $4.05M | ﹤0.01% |
292,299
+17,485
| +6% | +$253K |
|
|
JNCE
2921
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $4.05M | ﹤0.01% |
596,615
-26,261
| -4% | -$187K |
|
|
AHT
2922
Ashford Hospitality Trust
AHT
$21M
| $4.04M | ﹤0.01% |
39,631
-983
| -2% | -$87.7K |
|
2923
Rimini Street
RMNI
$447M
| $4.04M | ﹤0.01% |
696,163
+26,159
| +4% | +$137K |
|
2924
Harvard Bioscience
HBIO
$28.7M
| $4.03M | ﹤0.01% |
64,933
+643
| +1% | +$38K |
|
2925
The ONE Group
STKS
$56.2M
| $4.03M | ﹤0.01% |
383,176
+23,881
| +7% | +$281K |
|
Similar funds
Geode Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, Geode Capital Management held 5,100 positions worth $801B, down 3.5% from $830B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Geode Capital Management's Q1 2022 filing shows 137 new, 3,081 increased, 1,102 reduced and 125 closed positions. Its largest new stake was Constellation Energy: 5,541,478 shares worth $311M. The largest sale was Xilinx Inc, an estimated $1.08B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q1 2022 buy was Constellation Energy: 5,541,478 shares worth $311M.
- Geode Capital Management added most to Apple in Q1 2022, an estimated $1.3B increase.
- Geode Capital Management's biggest Q1 2022 reduction was Merck, cutting an estimated $295M.
- Geode Capital Management fully exited Xilinx Inc in Q1 2022, selling an estimated $1.08B.
- Geode Capital Management's ten largest holdings make up 24% of its $801B portfolio in Q1 2022.
- Geode Capital Management opened 137 new positions and closed 125 in Q1 2022.
- Geode Capital Management's portfolio value fell 3.5% quarter-over-quarter to $801B.
Based on Geode Capital Management's 13F filing for Q1 2022, filed 13 May 2022.